Cargando…
P944: A PHASE I STUDY OF C-CAR088, A NOVEL HUMANIZED ANTI-BCMA CAR T CELL THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428951/ http://dx.doi.org/10.1097/01.HS9.0000846644.36411.51 |
| _version_ | 1784779279989473280 |
|---|---|
| author | Qu, X. An, G. Sui, W. Wang, T. Zhang, X. Yang, J. Zhang, Y. Zhang, L. Zhu, D. Huang, J. Zhu, S. Yao, X. Li, J. Zheng, C. Chen, S. Zhu, K. Wei, Y. Lv, X. Lan, L. Yao, Y. Zhou, D. Lu, P. Qiu, L. Li, J. |
| author_facet | Qu, X. An, G. Sui, W. Wang, T. Zhang, X. Yang, J. Zhang, Y. Zhang, L. Zhu, D. Huang, J. Zhu, S. Yao, X. Li, J. Zheng, C. Chen, S. Zhu, K. Wei, Y. Lv, X. Lan, L. Yao, Y. Zhou, D. Lu, P. Qiu, L. Li, J. |
| author_sort | Qu, X. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9428951 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94289512022-08-31 P944: A PHASE I STUDY OF C-CAR088, A NOVEL HUMANIZED ANTI-BCMA CAR T CELL THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA Qu, X. An, G. Sui, W. Wang, T. Zhang, X. Yang, J. Zhang, Y. Zhang, L. Zhu, D. Huang, J. Zhu, S. Yao, X. Li, J. Zheng, C. Chen, S. Zhu, K. Wei, Y. Lv, X. Lan, L. Yao, Y. Zhou, D. Lu, P. Qiu, L. Li, J. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9428951/ http://dx.doi.org/10.1097/01.HS9.0000846644.36411.51 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Qu, X. An, G. Sui, W. Wang, T. Zhang, X. Yang, J. Zhang, Y. Zhang, L. Zhu, D. Huang, J. Zhu, S. Yao, X. Li, J. Zheng, C. Chen, S. Zhu, K. Wei, Y. Lv, X. Lan, L. Yao, Y. Zhou, D. Lu, P. Qiu, L. Li, J. P944: A PHASE I STUDY OF C-CAR088, A NOVEL HUMANIZED ANTI-BCMA CAR T CELL THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title | P944: A PHASE I STUDY OF C-CAR088, A NOVEL HUMANIZED ANTI-BCMA CAR T CELL THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_full | P944: A PHASE I STUDY OF C-CAR088, A NOVEL HUMANIZED ANTI-BCMA CAR T CELL THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_fullStr | P944: A PHASE I STUDY OF C-CAR088, A NOVEL HUMANIZED ANTI-BCMA CAR T CELL THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_full_unstemmed | P944: A PHASE I STUDY OF C-CAR088, A NOVEL HUMANIZED ANTI-BCMA CAR T CELL THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_short | P944: A PHASE I STUDY OF C-CAR088, A NOVEL HUMANIZED ANTI-BCMA CAR T CELL THERAPY IN RELAPSED/REFRACTORY MULTIPLE MYELOMA |
| title_sort | p944: a phase i study of c-car088, a novel humanized anti-bcma car t cell therapy in relapsed/refractory multiple myeloma |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428951/ http://dx.doi.org/10.1097/01.HS9.0000846644.36411.51 |
| work_keys_str_mv | AT qux p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT ang p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT suiw p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT wangt p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT zhangx p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT yangj p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT zhangy p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT zhangl p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT zhud p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT huangj p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT zhus p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT yaox p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT lij p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT zhengc p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT chens p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT zhuk p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT weiy p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT lvx p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT lanl p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT yaoy p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT zhoud p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT lup p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT qiul p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma AT lij p944aphaseistudyofccar088anovelhumanizedantibcmacartcelltherapyinrelapsedrefractorymultiplemyeloma |